JITC – Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms | March 27, 2020 Share
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer | January 21, 2020 Share
Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program | August 14, 2018 Share
Use of FDA-Approved and Laboratory-Developed Tests in Advanced Non-Small Cell Lung Cancer: Results of a Retrospective Market Analysis | September 20, 2016 Share
Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer | April 7, 2016 Share
Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe. | April 7, 2016 Share
